To compare the patency duration of a peripheral intravenous cannula (PIVC) using either continuous infusion with 5% dextrose or intermittent flushing with 0.9% saline. Duration of PIVC patency was ...
COPENHAGEN, Denmark, June 18, 2025 /PRNewswire/ -- Droplet IV today announced the successful completion of a $2 million funding round to enable launch of its first automatic IV-line flushing device in ...
Feb. 1, 2005 -- The U.S. Food and Drug Administration (FDA) has issued a nationwide warning against the use of preloaded syringes containing either heparin or sodium chloride intravenous catheter ...
Investments in best-in-class manufacturing equipment position Sharps to offer differentiated high-volume syringe production to meet long-term contract demand NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) ...
Shares of Sharps Technology, Inc. (STSS) traded 24% higher by Wednesday noon after the company received a $400,000 purchase order from an IV flushing solutions provider. The medical device and ...
Milestone order marks first commercial revenue for Sharps Technology under multi-year, 500-million syringe agreementInvestments in best-in-class manufacturing equipment position Sharps to offer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results